European Cancer Forum 2025: Innovation, Security and Sustainability
DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
CancerWorld Issue #110 (December) is Live
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
1 event,
ESMO Course in Medical Oncology for Medical Students will be held from July 25-29, 2025 at Valencia, Spain. The ESMO Course in Medical Oncology for Medical Students is designed to inspire medical students to pursue a career in oncology. Organized by leading experts in collaboration with the ESMO Young Oncologists Committee, the course offers an […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
The ESMO Academy 2025 will take place in Prague, from 22 to 24 August 2025. The ESMO Academy 2025 offers an in-depth and comprehensive update on critical aspects of medical oncology. The event covers topics such as the methodology and interpretation of clinical trials, current standards of care, and future developments in major tumor types. […] |
1 event,
|
1 event,
|
|
0 events,
|
0 events,
|
1 event,
Virtual Event
The event "Therapeutic Landscapes: Management of IO Toxicities 2025" is an upcoming webinar hosted by ESMO (European Society for Medical Oncology) scheduled for August 27, 2025. It focuses specifically on the management of toxicities related to immuno-oncology (IO) therapies, which are increasingly used in cancer treatment. This event will address the challenges of identifying, monitoring, and […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|